OBJECTIVES: Based on continuous technical innovations and recent research, extracorporeal membrane oxygenation (ECMO) has become a promising tool in the treatment of patients with acute (cardio)pulmonary failure. Nevertheless, any extracorporeal technique requires a high degree of experience and knowledge, so that a restriction to specialized centres seems to be reasonable. As a consequence of this demand, the need for inter-hospital transfer of patients with severely impaired (cardio)pulmonary function is rising. Unfortunately, most of the ECMO devices used in the clinical setting are not suitable for inter-hospital transport because of their size, weight or complexity. In this article, we describe our first experiences with the airborne transport of 6 patients on a new portable, miniaturized and lightweight extracorporeal circulation system, the Medos deltastream® DP3. METHODS: Six patients suffering acute respiratory failure were taken on venovenous ECMO (DP3) out-of-centre and transferred to the University Medical Center Regensburg by helicopter. All cardiorespiratory-relevant parameters of the patients and the technical functioning of the device were continuously monitored and documented. RESULTS: Implantation of the device and air-supported transport were performed without any technical complications. The patients were transported from a distance of 66-178 km, requiring a time of 40-120 min. With the help of the new deltastream® DP3 ECMO device, a prompt stabilization of the cardiopulmonary function could be achieved in all patients. One patient was under ongoing cardiopulmonary resuscitation by the time our ECMO team arrived at the peripheral hospital and died shortly after arrival in the central emergency ward. CONCLUSIONS: Our experience shows that the deltastream® DP3 is an absolutely reliable and safe ECMO device that could gain growing importance in the field of airborne transportation of patients on ECMO due to its unsophisticated, miniaturized and lightweight characteristics.
OBJECTIVES: Based on continuous technical innovations and recent research, extracorporeal membrane oxygenation (ECMO) has become a promising tool in the treatment of patients with acute (cardio)pulmonary failure. Nevertheless, any extracorporeal technique requires a high degree of experience and knowledge, so that a restriction to specialized centres seems to be reasonable. As a consequence of this demand, the need for inter-hospital transfer of patients with severely impaired (cardio)pulmonary function is rising. Unfortunately, most of the ECMO devices used in the clinical setting are not suitable for inter-hospital transport because of their size, weight or complexity. In this article, we describe our first experiences with the airborne transport of 6 patients on a new portable, miniaturized and lightweight extracorporeal circulation system, the Medos deltastream® DP3. METHODS: Six patients suffering acute respiratory failure were taken on venovenous ECMO (DP3) out-of-centre and transferred to the University Medical Center Regensburg by helicopter. All cardiorespiratory-relevant parameters of the patients and the technical functioning of the device were continuously monitored and documented. RESULTS: Implantation of the device and air-supported transport were performed without any technical complications. The patients were transported from a distance of 66-178 km, requiring a time of 40-120 min. With the help of the new deltastream® DP3 ECMO device, a prompt stabilization of the cardiopulmonary function could be achieved in all patients. One patient was under ongoing cardiopulmonary resuscitation by the time our ECMO team arrived at the peripheral hospital and died shortly after arrival in the central emergency ward. CONCLUSIONS: Our experience shows that the deltastream® DP3 is an absolutely reliable and safe ECMO device that could gain growing importance in the field of airborne transportation of patients on ECMO due to its unsophisticated, miniaturized and lightweight characteristics.
Authors: Kanwal Kumar; Ryan Zarychanski; Dean D Bell; Rizwan Manji; Joel Zivot; Alan H Menkis; Rakesh C Arora Journal: Ann Thorac Surg Date: 2009-10 Impact factor: 4.330
Authors: J D Hill; T G O'Brien; J J Murray; L Dontigny; M L Bramson; J J Osborn; F Gerbode Journal: N Engl J Med Date: 1972-03-23 Impact factor: 91.245
Authors: Gina R Dorlac; Raymond Fang; Valerie M Pruitt; Peter A Marco; Heidi M Stewart; Stephen L Barnes; Warren C Dorlac Journal: J Trauma Date: 2009-04
Authors: Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne Journal: Lancet Date: 2009-09-15 Impact factor: 79.321
Authors: K Wagner; G K Sangolt; I Risnes; H M Karlsen; J E Nilsen; T Strand; L B Stenseth; J L Svennevig Journal: Perfusion Date: 2008-03 Impact factor: 1.972
Authors: Pier Paolo Terragni; Lorenzo Del Sorbo; Luciana Mascia; Rosario Urbino; Erica L Martin; Alberto Birocco; Chiara Faggiano; Michael Quintel; Luciano Gattinoni; V Marco Ranieri Journal: Anesthesiology Date: 2009-10 Impact factor: 7.892
Authors: Assad Haneya; Alois Philipp; Maik Foltan; Thomas Mueller; Daniele Camboni; Leopold Rupprecht; Thomas Puehler; Stephan Hirt; Michael Hilker; Reinhard Kobuch; Christof Schmid; Matthias Arlt Journal: Ann Saudi Med Date: 2009 Mar-Apr Impact factor: 1.526
Authors: Thomas Bascetta; Lauri Bolton; Ethan Kurtzman; William Hantzos; Heather Standish; Patricia Margarido; Kathleen Race; John Spencer; William Baker; Jason Gluck Journal: Air Med J Date: 2020-11-28